Natrium Chloratum Fresenius (Sodium Chloride)

Sodium Chloride, the active ingredient in Natrium Chloratum Fresenius, is an electrolyte solution presented as an injection solution for intravenous use. It is employed to replace lost fluids and correct electrolyte disturbances in patients requiring IV hydration during surgical procedures or trauma care.

GNH USA supplies Natrium Chloratum Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution to healthcare facilities, including clinics and transplant centres throughout.

Natrium Chloratum Fresenius is used in clinical situations that require rapid fluid and electrolyte restoration.

Fluid replacement: restores extracellular fluid volume in patients with dehydration, blood loss, or burns, helping maintain circulatory stability. Electrolyte balance: supplies sodium and chloride ions to correct hyponatremia or hypochloremia, supporting normal cellular function. IV hydration: provides an isotonic solution for intravenous hydration during surgery, intensive care, or when oral intake is not possible.

Sodium chloride injection may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort or soreness at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Transient hypernatremia: temporary rise in serum sodium levels. - Transient hyperchloremia: temporary increase in serum chloride levels.

Serious or Rare Side Effects: - Severe hypernatremia: marked elevation of sodium that can cause neurological symptoms. - Fluid overload: excessive volume leading to pulmonary edema or heart failure. - Allergic reaction: anaphylaxis or severe hypersensitivity requiring immediate medical attention.

When using Natrium Chloratum Fresenius, clinicians should observe several safety measures to minimize risks.

Patient assessment: evaluate fluid status and electrolyte levels before administration. Rate of infusion: adjust infusion speed to avoid rapid shifts in sodium concentration. Renal function: monitor patients with impaired kidney function for accumulation. Cardiac status: watch for signs of fluid overload, especially in heart disease. Compatibility: ensure the solution is compatible with other intravenous medications. Store at ambient temperature: keep in original container, protect from light and moisture.

Sodium chloride injection can interact with other therapies, influencing electrolyte balance or fluid status.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause dangerous hypernatremia. - High-dose potassium chloride: can precipitate electrolyte disturbances and cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal sodium loss, requiring careful monitoring. - ACE inhibitors or ARBs: may enhance risk of hyperkalemia when combined with potassium supplements. - Blood products: co‑administration may affect sodium load; monitor serum electrolytes.